This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation CAR & T Cell Therapies

LAST CHANCE: REGISTER BY MAY 20 TO SAVE UP TO $300

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
June 14-16, 2022
Delivered as a Hybrid EventIntercontinental Mark Hopkins Hotel, San Francisco, California

Amy Jensen Smith
Senior Director, Head of Discovery at SOTIO Biotech Inc., USA

Profile

Amy Jensen-Smith is the Senior Director, Head of Discovery Research at SOTIO where she and her team are committed to developing transformative next-gen CAR T therapies for patients with solid tumors. Prior to joining Sotio, Amy was responsible for building and leading target ID and validation and early drug discovery teams at bluebird bio and served as project lead for several CAR and TCR pipeline assets. Amy received her Ph.D. in immunology from Dartmouth Medical School in 2010. She performed post-doctoral research at the NCI under Steve Rosenberg and also completed an industry training postdoc at Novartis Institute for Biomedical Research.

Agenda Sessions

  • BOXR: A Platform for Improving T cell Performance in the Solid Tumor Microenvironment

    12:00pm